Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · IEX Real-Time Price · USD
0.410
+0.011 (2.76%)
Jun 20, 2024, 1:39 PM EDT - Market open

Alzamend Neuro Ratios and Metrics

Millions USD. Fiscal year is May - Apr.
Year
Current202320222021
Market Capitalization
35392-
Market Cap Growth
--42.57%--
Enterprise Value
34878-2
PE Ratio
-0.49-3.55-7.43-
PB Ratio
-1.4417.336.88-
P/FCF Ratio
-0.66-5.92-13.68-
P/OCF Ratio
-0.67-5.92-13.90-
EV/EBITDA Ratio
-0.47-3.21-6.320.33
EV/EBIT Ratio
-0.47-3.20-6.320.33
EV/FCF Ratio
-0.63-5.34-11.580.59
Debt / Equity Ratio
---0.17
Debt / EBITDA Ratio
----0.07
Debt / FCF Ratio
----0.12
Quick Ratio
0.071.7912.072.14
Current Ratio
0.162.0312.373.24
Interest Coverage
-1353.94-1930.98-264.71-30.78
Return on Equity (ROE)
1235.90%-206.10%-92.10%-356.10%
Return on Assets (ROA)
-481.20%-160.60%-84.90%-213.50%
Return on Capital (ROIC)
290.65%-488.28%-92.27%-210.88%
Earnings Yield
-421.39%-28.19%-13.45%-
FCF Yield
-313.48%-16.91%-7.31%-
Buyback Yield / Dilution
-7.62%-9.45%-22.64%-1.96%
Total Shareholder Return
-7.62%-9.45%-22.64%-1.96%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).